T3952

TPEN (TPEDA) is a specific cell-permeable heavy metal chelator.

AT-121 hydrochloride is a dual agonist of nociception and mu opioid receptor with Ki values of 3.67 and 16.49 nM, respectively.AT-121 hydrochloride is a safe, non-addictive, pain relieving compound with anti-injury and analgesic activity. AT-121 hydrochloride is a safe, non-addictive, pain relieving compound with anti-injury and analgesic activity.

Vamifeport (VIT-2763) is a novel orally active inhibitor that targets iron transport proteins and reduces markers of hemolysis in the SCD Townes model.VIT-2763 improves anemia and erythropoiesis, ameliorates vascular inflammation, and can be studied in β-thalassemia.

LEESGGGLVQPGGSMK, a proteolysis peptide, is a component of Infliximab, a chimeric monoclonal IgG1 antibody that selectively binds to TNF-α. It is used for the quantitative assessment of Infliximab.

HTL22562 is a CGRP receptor antagonist designed for the acute treatment of migraine.

Antitumor agent-28 is a compound that specifically targets and inhibits the activity of the ataxia telangiectasia mutated (ATM) kinase. By doing so, it effectively impedes the progression of ATM-mediated diseases and demonstrates significant anti-cancer activity.

Kgp-IN-1 hydrochloride is a novel compound, referred to as 13-R, which is an inhibitor of arginine-specific gingipain (Rgp).

Decanoyl-RVKR-CMK (DecRVKRcmk) TFA effectively hinders the processing of over-expressed gp160 and suppresses HIV-1 replication.

Se-DMC has antioxidant, anti-damage and anti-edema properties and can be used to study diseases related to metabolism and inflammation.

PCSK9-IN-2 is a newly developed small molecule that effectively inhibits the protein-protein interaction (PPI) between PCSK9 and LDLR. It has been found to have a potent inhibitory activity with an IC50 value of 7.57 μM.